

Apoorva Mandavilli
Science and global health reporter at The New York Times.
Top 10 podcasts with Apoorva Mandavilli
Ranked by the Snipd community

510 snips
Feb 13, 2025 • 25min
How Close Are We to Another Pandemic?
Apoorva Mandavilli, a science and global health reporter for The New York Times, dives into the alarming spread of the H5N1 bird flu virus and its potential impact on public health. She discusses how the virus has evolved, increasing risks to both animal and human populations. The conversation highlights the U.S. government's preparedness deficiencies and communication failures amid rising concerns of another pandemic. With egg prices skyrocketing and public trust eroding, Mandavilli emphasizes the urgent need for effective responses to future health crises.

332 snips
May 28, 2025 • 29min
R.F.K. Jr. Sends a Message on Vaccines
Apoorva Mandavilli, a science and global health reporter at The New York Times, discusses a recent controversial decision by the Trump administration regarding COVID-19 vaccinations for children and pregnant women. She delves into how this abrupt change in guidelines could affect public health and vaccine accessibility. The conversation touches on the implications for vulnerable populations, the safety of vaccines for young children, and the concerns raised by medical experts regarding the rationale behind these shifts. It's a critical examination of the intersection of health policy and public trust.

38 snips
Feb 3, 2023 • 20min
The End of the Pandemic Emergency in the U.S.
Apoorva Mandavilli, a science and global health reporter for The New York Times, delves into the implications of the Biden administration's decision to end the COVID-19 public health emergency. This transition signals a new phase in pandemic response, complicating access to tests and treatments, particularly for those uninsured. The conversation also touches on the political ramifications of ceasing Title 42 and addresses the evolving perspectives on living with COVID-19, emphasizing the importance of personal risk assessments as society adapts to a new normal.

18 snips
Sep 13, 2023 • 26min
A New Covid Shot for a New Covid Era
Apoorva Mandavilli, a science and global health reporter for The New York Times, delves into the recent shift to annual COVID vaccinations. She discusses the end of booster shots and the strategic changes as infections rise again. Mandavilli explains who should get the new vaccine and when, while emphasizing the importance of vaccination against long-term effects. The conversation also touches on adapting to evolving public health guidelines, personal responsibility, and the broader implications of these changes amid ongoing global events.

18 snips
Nov 22, 2022 • 26min
The ‘Tripledemic’ Explained
Apoorva Mandavilli, a science and global health reporter for The New York Times, dives into the looming ‘tripledemic’ of RSV, flu, and COVID-19. She explores why children are facing the brunt of these viral infections, sharing a heartfelt story of a mother whose infant struggled with severe RSV. The discussion also highlights limited treatments, the importance of vaccinations, and the challenges posed by new COVID variants as winter approaches. Mandavilli emphasizes the critical need for public health awareness and vigilance.

17 snips
Jun 6, 2024 • 23min
The Fight Over the Next Pandemic
Apoorva Mandavilli, a seasoned science and global health reporter for The New York Times, dives into the faltering negotiations for a global pandemic preparedness treaty. She discusses the stark vaccine inequities revealed during COVID, highlighting the struggles of lower-income nations. Mandavilli sheds light on the complex power dynamics with pharmaceutical companies and emphasizes the urgent need for equitable health solutions. Her frontline reporting showcases the critical role of journalists in conveying this crucial information during crises.

10 snips
Aug 20, 2024 • 28min
Experts warn bird flu poses ‘an existential threat’ to biodiversity, and a possible threat to humans
Apoorva Mandavilli, a science and health journalist for The New York Times, discusses the H5N1 bird flu outbreak, dubbed an 'existential threat' to biodiversity. She outlines how the virus is impacting wildlife and the potential risks to human health. Mandavilli highlights the role of environmental degradation and industrial agriculture in exacerbating this crisis. Furthermore, she critiques U.S. pandemic response measures and underscores the urgent need for improved monitoring and vaccination strategies to combat this adaptable virus.

6 snips
Feb 14, 2025 • 60min
Lab-grown chocolate, bird flu, beans, egg substitutes
Gabriela Glueck, the Julia Child fellow, dives into the world of lab-grown chocolate, revealing its sustainable production methods. Apoorva Mandavilli discusses the rising threat of bird flu and its impact on food supply and egg prices. Genevieve Ko shares innovative egg substitutes like aquafaba and flax gel for cooking. Steve Sando, of Rancho Gordo, showcases the versatility of heirloom beans while sharing culinary tips. From chocolate alternatives to bean cooking secrets, this chat mixes science with culinary creativity!

4 snips
Aug 1, 2022 • 24min
How Monkeypox Went From Containable to Crisis
Apoorva Mandavilli, a science and global health reporter for The New York Times, dives into the alarming spread of monkeypox in the U.S. Initially deemed manageable, the virus quickly escalated into a public health crisis. Apoorva discusses challenges in testing and vaccination, particularly affecting the LGBTQ+ community. She shares personal accounts of individuals facing difficulties in securing treatment. The conversation sheds light on systemic weaknesses in the public health infrastructure and the urgent need for improved responses to outbreaks.

Apr 28, 2022 • 24min
Most of Us Have Had Covid
Apoorva Mandavilli, a science and global health reporter for The New York Times, dives into the staggering statistic that around 60% of Americans have been infected with COVID-19. She discusses the elusive nature of herd immunity and the ongoing risks faced by the population, especially children. The conversation also touches on the complexity of vaccination strategies, personal risk assessments, and the ethical challenges surrounding post-exposure testing. Mandavilli emphasizes the shift in public health goals towards preventing severe illness rather than simply counting infections.